S. Ughetto
6 Papers
47 Citations
S. Ughetto is an academic researcher. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 6, co-authored 6 publications.
Chat about Author
Papers
Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study
Audrey Mirand,Cécile Henquell,Christine Archimbaud,S. Ughetto,Denise Antona,Jean-Luc Bailly,Hélène Peigue-Lafeuille +6 more
TL;DR: A sentinel surveillance system involving paediatricians from Clermont-Ferrand (France) was set up to determine the clinical and epidemiological characteristics of HFMD/HA associated with enterovirus infections, and the outbreak described in this population survey was caused by coxsackievirus A6 and coxsacksackiev virus A10, the third dual outbreak in Europe in the last 3 years.
279
Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis.
Christine Archimbaud,Martine Chambon,Jean-Luc Bailly,Isabelle Petit,Cécile Henquell,Audrey Mirand,B. Aublet-Cuvelier,S. Ughetto,J. Beytout,Pierre Clavelou,André Labbé,P. Philippe,Jeannot Schmidt,Christel Regagnon,O. Traore,Hélène Peigue-Lafeuille +15 more
TL;DR: The EV‐PCR assay should be performed daily in hospital laboratory practice and considered as part of the initial management of meningitis in infants, children, and adults.
107
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis.
Armand Abergel,C Darcha,M. Chevallier,S. Ughetto,C Henquell,Stanislas Pol,de Ledinghen,Canva,Jean-Pierre Bronowicki,Albert Tran,N Martineau,H. Lafeuille,Pierre Déchelotte,G. Bommelaer,C Bonny +14 more
TL;DR: Interferon can slow fibrosis progression in sustained virological responders with severe fibrosis and in patients with a non-virological response, meaning that only fibrosis stabilization could be obtained in these patients.
31
The epidemiology and virology of hepatitis C virus genotype 5 in central France.
A. Abergel,S. Ughetto,S. Dubost,C. Bonny,B. Aublet-Cuvelier,E. Delarocque-Astagneau,Jean-Luc Bailly,G. Bommelaer,S. Casanova,J. Delteil,P. Deny,H. Laurichesse,Hélène Odent-Malaure,J. Roussel,Hélène Peigue-Lafeuille,Cécile Henquell +15 more
TL;DR: This data indicates that high prevalence of hepatitis C virus genotype 5a (HCV 5) (14%) in Central France is a new phenomenon and needs to be investigated further to establish a causative mechanism.
19